A PHASE 4, 52-WEEK (PRIMARY ANALYSIS AT 24-WEEKS), RANDOMIZED, STRATIFIED, OPEN-LABEL, ACTIVE-CONTROLLED, PARALLEL-GROUP, EFFECTIVENESS STUDY, COMPARING FF/UMEC/VI WITH NON-ELLIPTA USUAL CARE (ICS/LABA) IN ADULT PARTICIPANTS WITH UNCONTROLLED ASTHMA

One Response

Leave a Reply

Your email address will not be published. Required fields are marked *